These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29609948)

  • 21. Drug insight: the role of statins in combination with ezetimibe to lower LDL cholesterol.
    Gotto AM; Farmer JA
    Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):664-72. PubMed ID: 17122799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of treat-to-target strategy for LDL-cholesterol control in type 2 diabetes: post-hoc analysis of data from the MIND.IT study.
    Ardigò D; Vaccaro O; Cavalot F; Rivellese AA; Franzini L; Miccoli R; Patti L; Boemi M; Trovati M; Zavaroni I;
    Eur J Prev Cardiol; 2014 Apr; 21(4):456-63. PubMed ID: 23147277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High cardiovascular risk in patients with diabetes and the cardiometabolic syndrome: mandate for statin therapy.
    Gonzalez GL; Manrique CM; Sowers JR
    J Cardiometab Syndr; 2006; 1(3):178-83. PubMed ID: 17679817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Under-prescription of statins in patients with non-alcoholic fatty liver disease.
    Del Ben M; Baratta F; Polimeni L; Pastori D; Loffredo L; Averna M; Violi F; Angelico F
    Nutr Metab Cardiovasc Dis; 2017 Feb; 27(2):161-167. PubMed ID: 27914698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implementation of a new guideline in cardiovascular secondary preventive care: subanalysis of a randomized controlled trial.
    Jakobsson S; Huber D; Björklund F; Mooe T
    BMC Cardiovasc Disord; 2016 Apr; 16():77. PubMed ID: 27129980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of Low Density Lipoprotein Cholesterol at a primary care diabetes clinic in Kuwait.
    Nassif A; Katoue MG; Wake DJ; George J
    Prim Care Diabetes; 2019 Jun; 13(3):259-265. PubMed ID: 30578166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low rates of both lipid-lowering therapy use and achievement of low-density lipoprotein cholesterol targets in individuals at high-risk for cardiovascular disease across Europe.
    Halcox JP; Tubach F; Lopez-Garcia E; De Backer G; Borghi C; Dallongeville J; Guallar E; Medina J; Perk J; Sazova O; Sweet S; Roy C; Banegas JR; Rodriguez-Artalejo F
    PLoS One; 2015; 10(2):e0115270. PubMed ID: 25692692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of dyslipidemia in 2014: European versus American guidelines].
    Radermecker RP
    Rev Med Suisse; 2014 Aug; 10(439):1534-7. PubMed ID: 25272669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Universal screening and drug treatment of dyslipidemia in children and adolescents.
    Psaty BM; Rivara FP
    JAMA; 2012 Jan; 307(3):257-8. PubMed ID: 22174386
    [No Abstract]   [Full Text] [Related]  

  • 30. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
    Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
    Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-achievement of LDL-cholesterol targets in patients with diabetes at very-high cardiovascular risk receiving statin treatment: Incidence and risk factors.
    Breuker C; Clement F; Mura T; Macioce V; Castet-Nicolas A; Audurier Y; Boegner C; Morcrette E; Jalabert A; Villiet M; Avignon A; Sultan A
    Int J Cardiol; 2018 Oct; 268():195-199. PubMed ID: 30041785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipid target achievement among patients with very high and high cardiovascular risk in a lipid clinic.
    Barkas F; Liberopoulos EN; Kostapanos MS; Liamis G; Tziallas D; Elisaf M
    Angiology; 2015 Apr; 66(4):346-53. PubMed ID: 24830420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Residual dyslipidaemia after statin treatment in France: Prevalence and risk distribution.
    Ferrières J; Bérard E; Crisan O; Bongard V
    Arch Cardiovasc Dis; 2010 May; 103(5):302-9. PubMed ID: 20619240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Are the ACC/AHA guidelines on the treatment of blood cholesterol a game changer? A perspective from the Canadian Cardiovascular Society Dyslipidemia Panel.
    Anderson TJ; Grégoire J; Hegele RA; Couture P; Mancini GB; McPherson R; Francis GA; Poirier P; Lau DC; Grover S; Genest J; Carpentier AC; Dufour R; Gupta M; Ward R; Leiter LA; Lonn E; Ng DS; Pearson GJ; Yates GM; Stone JA; Ur E
    Can J Cardiol; 2014 Apr; 30(4):377-80. PubMed ID: 24589194
    [No Abstract]   [Full Text] [Related]  

  • 35. [Lipid-lowering cardiovascular prevention in type 2-diabetes. Statins are effective according to the FIELD study].
    Båvenholm P; Attvall S; Nilsson PM
    Lakartidningen; 2006 Aug 30-Sep 5; 103(35):2462-6. PubMed ID: 17002161
    [No Abstract]   [Full Text] [Related]  

  • 36. [Importance of dyslipidaemia in cardiovascular disease: a point of view].
    Ascaso JF; Carmena R
    Clin Investig Arterioscler; 2015; 27(6):301-8. PubMed ID: 26363575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-density lipoprotein cholesterol in a global cohort of 57,885 statin-treated patients.
    Gitt AK; Lautsch D; Ferrieres J; Kastelein J; Drexel H; Horack M; Brudi P; Vanneste B; Bramlage P; Chazelle F; Sazonov V; Ambegaonkar B
    Atherosclerosis; 2016 Dec; 255():200-209. PubMed ID: 27667299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Counterpoint: Low-density lipoprotein cholesterol goals in patients with diabetes are adequately based on evidence.
    Davidson MH
    J Clin Lipidol; 2010; 4(1):72-3; discussion 74. PubMed ID: 21122630
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparative long-term efficacy and tolerability of pitavastatin 4 mg and atorvastatin 20-40 mg in patients with type 2 diabetes mellitus and combined (mixed) dyslipidaemia.
    Gumprecht J; Gosho M; Budinski D; Hounslow N
    Diabetes Obes Metab; 2011 Nov; 13(11):1047-55. PubMed ID: 21812889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The gap between the current dyslipidemia guidelines and the physicians' treatment targets in patients with type 2 diabetes in Turkey.
    Kahya Eren N; Harman E; Dolek D; Emren S; Tütüncüoğlu AP; Nazli C; Ergene O
    Minerva Cardioangiol; 2014 Jun; 62(3):287-95. PubMed ID: 24831765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.